Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group.
about
Pulmonary applications and toxicity of engineered nanoparticlesDrug delivery and nanoparticles:applications and hazardsLost in Translation: Obstacles to Translational MedicineNanoparticle-induced platelet aggregation and vascular thrombosisPatent ductus arteriosus in premature infants: A never-closing act.Nanodevices in diagnostics.Nanoparticles in drug delivery and environmental exposure: same size, same risks?Native and Reconstituted Plasma Lipoproteins in Nanomedicine: Physicochemical Determinants of Nanoparticle Structure, Stability, and Metabolism.Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB/c mice.Role and implications of nanodiagnostics in the changing trends of clinical diagnosisNanomedicine in cardiovascular therapy: recent advancements.Gd(3+)-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent.The impact of effective patents on future innovations in nanomedicine.Blood compatible carbon nanotubes--nano-based neoproteoglycans.Cardiovascular nanomedicine: a posse ad esse.The Cochrane Library and treatment of patent ductus arteriosus: an overview of reviews
P2860
Q24650775-106667AC-641E-453F-A7C2-A2A0EF7641FAQ24655744-F554BDB7-B2BD-407F-9B46-0052E47B54D7Q24807071-8F233ED7-F716-48B9-B5B1-F2C1B85398EBQ28191813-22F085C8-8E5D-4497-853D-762EC4524DBBQ34030439-F618C3C0-2EEA-4E0B-B843-2216BE756DF4Q34234274-9CF109B1-E886-4E23-9A4A-1F4522A84E07Q36917908-5D966093-0494-4300-8C51-08DBA9C29B64Q37397956-48D5E4AB-274B-4CC7-A436-34CAF4FBEA82Q37413093-718157AC-32A0-40B8-AC66-81B7B5C6E45BQ37618012-5546F6DB-F84E-4EDE-AAD9-C0F10377AC34Q38034812-78199F19-28D9-4E05-A47E-8032F9E843B8Q39540783-C6176D9B-4B69-46E9-A55B-17EF6BEB3D93Q39649136-FA3F2741-D886-4C67-B5AB-98AFACE8F446Q42754172-15F3376B-0D61-49B4-84CA-678F04DE4A46Q43232585-80B8F8FC-7BB6-4D21-95A7-C491DF7E0E0CQ58811602-514C0C6E-6AE5-499E-AD32-98AE31D10D81
P2860
Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Recommendations of the Nationa ...... Nanotechnology Working Group.
@ast
Recommendations of the Nationa ...... Nanotechnology Working Group.
@en
type
label
Recommendations of the Nationa ...... Nanotechnology Working Group.
@ast
Recommendations of the Nationa ...... Nanotechnology Working Group.
@en
prefLabel
Recommendations of the Nationa ...... Nanotechnology Working Group.
@ast
Recommendations of the Nationa ...... Nanotechnology Working Group.
@en
P2093
P1433
P1476
Recommendations of the Nationa ...... e Nanotechnology Working Group
@en
P2093
Mauro Ferrari
National Heart, Lung, and Blood Institute Nanotechnology Working Group
Samuel A Wickline
Stephen C Lee
P304
P356
10.1161/01.CIR.0000096493.93058.E8
P407
P50
P577
2003-12-01T00:00:00Z